ACAT2 and nonpapillary renal cell carcinoma: miR-1233 directly targets cholesteryl transferase 2 (ACAT2) and is a target of circ-RPL23A, which inhibits clear cell renal cell carcinoma (ccRCC) progression by competitively binding miR-1233 and thus upregulating ACAT2 expression (48).